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Abstract 
Human T-cell leukemia virus type 1 oncoprotein Tax is a transcriptional regulator that 
interacts with a large number of host cell factors. Here, we report the novel 
characterization of the interaction of Tax with a human cell protein named TAX1BP1. We 
show that TAX1BP1 is a nuclear receptor co-activator that forms a complex with 
glucocorticoid receptor. TAX1BP1 and Tax co-localize into intranuclear speckles that 
partially overlap with but are not identical to the PML oncogenic domains. Tax binds 
TAX1BP1 directly, induces the dissociation of TAX1BP1 from the glucocorticoid receptor-
containing protein complex, and represses TAX1BP1’s co-activator function. Genetic 
knockout of Tax1bp1 in mice abrogates the influence of Tax on the activation of nuclear 
receptors. We propose that Tax-TAX1BP1 interaction mechanistically explains the 
previously reported repression of nuclear receptor activity by Tax.    
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Introduction 
Human T-cell leukemia virus type 1 (HTLV-1) was the first retrovirus shown to be associated 
with a human disease, adult T cell leukemia (ATL). ATL is an aggressive neoplasm; however, its 
induction by HTLV-1 is a slow process which takes 20 to 40 years and apparently requires the 
consummation of several discrete events in the virus-infected cell (1). 
The HTLV-1 Tax oncoprotein can immortalize T cells and transforms rat fibroblasts (2). Tax is a 
transcriptional factor, which targets the HTLV-1 long terminal repeats (LTR), heterologous viral 
promoters, and a variety of cellular genes (3) Tax acts potently through Tax-responsive (TRE) DNA 
elements on the LTR which are also cAMP-responsive motifs recognized by the cellular 
transcription factor CREB; Tax can also activate NFκB (3). In various settings, Tax has been found 
to repress the expression of cellular genes including DNA polymerase β (4), p53 (5, 6), nuclear 
receptors (7), cyclin A (8), c-Myb (9), MyoD (10) and transforming growth factor β (11). 
Transcriptional activation of gene expression exerted by Tax through either the CREB or the 
NFκB pathway has been well studied. Accordingly, we understand that Tax functions as a homo-
dimer (12, 13), which docks with dimeric CREB in a ternary complex onto the HTLV-1  21-bp TRE 
motifs (14). Optimal activation of the HTLV-1 LTR by Tax requires the core HTLV-1 TATAA 
promoter, CREB and the TRE (15). Separately, Tax activation of NFκB is thought to occur through 
direct interaction with p50/p52, IκB and IKKγ (3). Moreover, Tax can also engage transcriptional 
co-activators such as CREB-binding protein (CBP), p300, P/CAF and TORC1/2/3 (16-18).   
While we know much about how Tax activates transcription, we know considerably less about 
how it represses gene expression.  Several ideas have been forwarded as to how Tax may repress the 
expression of cellular genes.  For example, Tax has been reported to suppress the transcription of the 
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DNA polymerase β gene via direct inhibition of basic helix-loop-helix factors (19). Tax attenuates 
cyclin A expression through sequestration of  CREB/ATF (8), and Tax suppresses transforming 
growth factor β indirectly by activating the NFκB and c-Jun signaling pathways, respectively (9, 
11). Finally, Tax physically binds general transcription co-activators such as CBP, p300 and P/CAF 
(10, 20); its ability to inactivate the function of the p53 tumor suppressor and other targets is thought 
to be mediated at least partially through binding to CBP and/or p300 (9, 10, 20). 
Nuclear receptors (NRs) are a large family of ligand-activated transcription factors that regulate 
gene expression in response to steroids, retinoids and other signaling molecules (21). These 
transcription factors play an important role in regulating development, differentiation, metabolism 
and cell proliferation. Dysregulation of nuclear factor-dependent transcription leads to various 
diseases including cancer (22). A few years ago, Doucas and Evans reported that the HTLV-1 Tax 
protein is a general repressor of the transcriptional capacity of several NRs including glucocorticoid 
receptor (GR) (7). To date, it has remained unclear how Tax mechanistically suppresses the activity 
of NRs. Here we show that TAX1BP1, a human cell encoded Tax-binding protein identified by us 
(23), is closely related to coiled-coil transcriptional coactivator (CoCoA), a component of the p160 NR 
coactivator complex (24, 25). We further show that TAX1BP1 is a transcriptional coactivator for 
NR, and that Tax represses NR function through binding to TAX1BP1.   
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Materials and Methods 
Plasmids. Human TAX1BP1 cDNA containing a complete coding region (GenBank 
U33821) was derived from an EST clone (ATCC: 104248) obtained from the American Type 
Culture Collection. Expression plasmids pSVBP1 and pHABP1 for full-length TAX1BP1 were 
derived from previously described SV40 promoter-driven expression vectors pSV and pHA (26, 
27). Plasmid pGSTBP1 contains TAX1BP1 cDNA inserted into pGEX4T3 (Amersham). 
TAX1BP1, Tax and the activation domain of VP16 fused to Gal4 DNA binding domain (amino 
acids 1-147) were designated GalBP1, GalTax and GalVP16, respectively. Mammalian 
expression plasmid pGALBP1 expressing GalBP1 was derived from pM (Clontech). Truncated 
versions of TAX1BP1 were constructed by PCR and the sequences of all mutants were 
determined to confirm that no undesired changes were introduced. Mouse Tax1bp1 cDNA 
(IMAGE: 1480596) in an SV40 promoter-driven expression vector pME18S-FL3 was purchased 
from the American Type Culture Collection.   
Expression plasmids for Tax, GalTax and polyhistidine-tagged Tax (His-Tax) have been 
described elsewhere (15, 18). Expression plasmid for GalVP16 was from Clontech.    
Chloramphenicol acetyltransferase (CAT) reporter plasmid pG5CAT containing five copies 
of Gal4-binding sites was from Clontech. Luciferase reporter plasmid pLTRLuc under the 
control of the HTLV-1 LTR has been described elsewhere (15). Reporter plasmids pκBLuc, 
pSRELuc and pCRELuc were from Stratagene. pGRELuc was from Clontech. 
Expression plasmid pCDNArGR  (28) for rat glucocorticoid receptor (GR) was kindly 
provided by Dr. Keith Yamamoto (University of California, San Francisco, California, USA). 
Expression plasmid pSG5TIF2 (29) for human glucocorticoid receptor-interacting protein 1 
(GRIP1), also known as transcriptional intermediary factor 2 (TIF2), was a gift from Dr. Hinrich 
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Gronemeyer (Institut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch Cedex, 
France). 
Antibodies. Polyclonal anti-TAX1BP1 antibody α-151C was raised in rabbits against a 
keyhole limpet hemocyanin-conjugated synthetic peptide which corresponds to the C-terminal 21 
residues (amino acids 725-747) of human TAX1BP1. Likewise, α-151A was against a 
conjugated peptide corresponding to amino acid residues 537-556 of human TAX1BP1. α-151C 
and α-151A antisera were purified through HiTrap Sepharose columns (Amersham) activated by 
N-hydroxysuccinimide and coupled to immunizing peptides.   
Mouse monoclonal anti-Tax antibody (clone 168A51-42) and rabbit polyclonal antiserum 
against Tax have been described (26, 30). Mouse monoclonal anti-α-tubulin (clone B-5-1-2) was 
from Sigma. Mouse monoclonal anti-HA (clone F-7), anti-PML (clone PG-M3) and anti-GR 
(clone FiGR) antibodies as well as rabbit polyclonal antiserum H300 against GR were from 
Santa-Cruz. Rabbit polyclonal antiserum against Gal4 activation domain (AD) was from Upstate.  
GST pull-down assay. Recombinant proteins GST, GST-TAX1BP1 and His-Tax were 
expressed from Escherichia coli and purified as previously described (30). Briefly, equal 
amounts of His-Tax were loaded onto GST- or GST-TAX1BP1-bound glutathione-Sepharose 
(Amersham) and flow-through fractions were collected. The resins were washed with three 
changes of buffer A (20 mM HEPES-KOH, pH 7.9, 20 mM KCl, 1 mM MgCl2, 17% glycerol, 
and 2 mM dithiothreitol) and eluted with buffer A containing 0.5 M KCl. The eluates were 
precipitated with trichloroacetic acid, solubilized and then analyzed by SDS-PAGE and Western 
blotting.  
Protein analysis. Yeast two-hybrid assays based on Gal4 DNA-binding and activation 
domain fusions were carried out in strains SFY526, CG1945 and Y187 as previously described 
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(13, 30). Experimental procedures for immunoprecipitation and Western blotting have also been 
detailed elsewhere (27, 31).  
Confocal microscopy. Laser scanning confocal microscopy was performed as previously 
described (27, 32). Dual immunofluorescent detection was achieved with primary antibodies 
from different species and pre-adsorbed species-specific secondary antibodies conjugated to Cy5 
or fluorescein (Zymed). Co-localization of proteins was based on multicolor imaging and was 
analyzed with Zeiss LSM510 software.  
Reporter assay. HeLa cells and mouse embryonic fibroblasts (MEF) were grown in 
Dulbecco’s modified Eagle’s medium. HeLa cells were transfected by calcium phosphate 
precipitation method for CAT assay (13, 26). HeLa and MEF cells were transfected by 
LipofectAMINE 2000TM reagent (Invitrogen) for luciferase assay (33). Jurkat, JPX9 and MT4 
cells were cultured in RPMI 1640 medium and transfected by electroporation (18). 
CAT activity was assayed by thin-layer chromatography as previously described (13, 31). 
Protein concentration of clarified lysates was determined by Bradford reagent (Bio-Rad) and 
equal amounts of proteins were added to the CAT reaction. Transfection efficiencies were 
normalized with a pSV-β-Gal control plasmid (Promega) expressing β-galactosidase.  
Luciferase activity was measured as described (33) using the Dual-Luciferase® reagents 
(Promega). Transfection efficiencies were normalized with a pRL-TK control plasmid (Promega) 
expressing Renilla luciferase. 
Generation of Tax1bp1+/- and Tax1bp1-/- mice. The Tax1bp1 gene is located on 
chromosome 6.  A 12kb EcoRI-BamHI fragment which contains exon 16 and 17 was used for 
generation of targeting plasmid.  The thymidine kinase  (TK) and the neomycin (neo) genes were 
used as selectable markers. In engineering the knock out mice,  exon 17 of Tax1bp1 was replaced 
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by neo. Confirmation of successful knockout was based on PCR and Western blotting. Details on 
knock out and in breeding of Tax1bp1-/- animals are presented elsewhere (Iha et al., in 
preparation).   
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Results 
Interaction of TAX1BP1 and Tax. We screened a human cDNA library for Tax-binding 
proteins using yeast two-hybrid technology. One Tax-binding cDNA was initially designated 
TXBP151 (GenBank U33821) and was subsequently named by the Gene Nomenclature 
Committee of the Human Genome Organization as “Tax1-binding protein 1 (TAX1BP1)”. 
TAX1BP1 has 747 amino acid residues, and its molecular mass is predicted to be 86.5 kDa. We 
previously reported that TAX1BP1 interacts with A20, which is an inhibitor of apoptosis and 
NFκB signaling (23). Moreover, others have identified TAX1BP1 as T6BP, a TRAF6-binding 
protein (34). 
TAX1BP1 contains an N-terminal domain (residues 1-150) homologous to nuclear dot 
protein 52 (NDP52), whose function remains elusive and controversial (35). The central region 
(residues 150-600) of TAX1BP1 is predicted to form a coiled-coil structure (36). The C-terminal 
part (residues 668-747) of TAX1BP1 harbors zinc finger motifs (Fig. 1A). Interestingly, the full 
TAX1BP1 protein also shares 27% identity and 45% similarity with a newly-identified coiled-
coil transcriptional coactivator CoCoA (24, 25). We found that the TAX1BP1 mRNA is 
ubiquitously expressed in various human tissues (data not shown).   
As a first step towards understanding TAX1BP1 and its interaction with Tax, we raised two 
antisera α-151C and α-151A in rabbits against synthetic TAX1BP1 peptides conjugated to 
keyhole limpet hemocyanin. These antibodies specifically recognized TAX1BP1 expressed in 
cultured human cells. For example, α-151C reacted with endogenous TAX1BP1 of ~85 kDa in 
size in HeLa cells (Fig. 1B, lanes 1 and 3) and in HTLV-1-transformed MT4 cells (lane 4). In 
addition, α-151C was also reactive to TAX1BP1 exogenously expressed from a plasmid 
transiently transfected into HeLa cells (Fig. 1B, lane 2 compared to lanes 1 and 3).  
 10 
Using α-151C and a mouse monoclonal antibody against Tax, we performed reciprocal co-
immunoprecipitation and immunoblotting experiments to characterize the interaction of 
TAX1BP1 and Tax in cultured cells. Indeed, either α-Tax or α-151C was able to precipitate both 
Tax and TAX1BP1 proteins from Tax-expressing HeLa cells (Fig. 1B, lane 3) and HTLV-
transformed MT4 cells derived from T lymphocytes (lane 4). By contrast, the formation of Tax-
TAX1BP1 complex was not seen in mock- or TAX1BP1-transfected HeLa cells (Fig. 1B, lanes 1 
and 2), which did not express Tax. Additionally, we also confirmed the interaction between 
TAX1BP1 and Tax using GST pull-down assay. Here, purified polyhistidine-tagged Tax protein 
(His-Tax) bound to GST-TAX1BP1 resin (Fig. 1C, lane 4), but not to GST (lane 2). Notably, our 
data on the interaction of TAX1BP1 and Tax are consistent with findings from yeast two-hybrid 
and mass spectrometric analyses of Tax-associated proteins in HTLV-1-transformed MT2 and 
C8166 lymphoblastic cells (37, 38). 
We mapped the Tax-binding domain in TAX1BP1 to amino acid residues 184-445 (M4; Fig. 
1D). We defined this domain based on the Tax-binding activities of 7 TAX1BP1 mutants 
initially in yeast two-hybrid assays which were subsequently verified by GST pull-downs. The 
expression of the three mutants that were unable to bind with either Tax or TAX1BP1 was 
verified by Western blotting (Fig. 1D, inset). In both yeast two-hybrid assays and GST-pull 
down experiments, we discovered that TAX1BP1 also forms a homodimer. Thus, TAX1BP1’s 
self-dimerization domain resides within amino acid residues 446-600 (M7; Fig. 1D).     
Co-localization of TAX1BP1 with Tax and PML. To check that Tax and TAX1BP1 would 
interact intracellularly, we next queried the subcellular localization of TAX1BP1 using α-151C 
and α-151A (Fig. 2A). We stained HeLa cells with either α-151C or α-151C affinity-purified 
using the immunizing peptides (Fig. 2A, panels 1 and 4). Cells were also co-stained for α-
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tubulin, in order to orient the general cellular  morphology (Fig. 2A, panels 2, 5 and 8). We 
observed that cell-endogenous TAX1BP1 was concentrated into intranuclear speckles (Fig. 2A, 
panels 1 and 3). In support of the specificity of this TAX1BP1 staining, the speckles disappeared 
when cells were stained with α-151C pre-absorbed with the immunizing peptide (Fig. 2A, panels 
4 and 6). As confirmation of the staining pattern, HeLa cells visualized using α-151A provided a 
TAX1BP1-pattern like that observed with α-151C  (Fig. 2A, compare panel 7 to panel 1).   
To assess the localization of TAX1BP1 expressed from a plasmid, we stained HeLa cells 
transiently transfected with an expression vector for HA-tagged TAX1BP1. Generally in keeping 
with staining pattern of  endogenous TAX1BP1, an anti-HA antibody reacted with TAX1BP1 
speckles in transfected cells (Fig. 2B, panel 2). Consistent with results from Western blot 
analysis in which α-151C specifically recognized both endogenous and transfected TAX1BP1  
(Fig. 1B), the intranuclear speckles bound to anti-HA overlapped substantially (84.3 ± 4.5%) 
with those reactive to α-151C (Fig. 2B, panels 1 and 3). 
Above we demonstrated that TAX1BP1 localizes to intranuclear speckles (Fig. 2). Because 
Tax was also previously found in intranuclear speckles (7, 39, 40), we next asked whether 
TAX1BP1 and Tax might appear together intracellularly, and how one might affect the 
localization of the other.  
When we co-stained Tax-expressing cells for TAX1BP1 and Tax, we noted that both 
appeared in the nucleus and were concentrated in speckles (Fig. 3A, panels 1 and 2). As 
indicated by computer-assisted co-localization study, there was 89.1 ± 5.2% overlap between 
Tax-containing speckles and the TAX1BP1 dots (Fig. 3A, panel 3). Thus, TAX1BP1 co-
localized with Tax to the same intranuclear structure. Interestingly, the localization of TAX1BP1 
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did not change noticeably upon the expression  of Tax (Fig. 3A, panel 1, compared to Fig. 2A, 
panel 1).   
The Tax- and TAX1BP1-containing speckles were similar to PML oncogenic domains in 
appearance. In addition, PML has been shown to modulate Tax function in different contexts (7, 
41). However, previous findings on the co-localization of Tax with PML remain controversial. 
While one group has suggested the residence of Tax in PML domains (7), others have also found 
that Tax and PML are separate (41). To clarify this issue, we co-stained Tax-expressing cells for 
Tax and PML. Fig. 3B indicates that the Tax-containing speckles were similar but distinct from 
PML domains. Hence, there was 48.5 ± 6.0% co-localization between Tax and PML (Fig. 3B, 
panel 3). Likewise, the TAX1BP1 speckles were not identical with the PML dots (Fig. 3C). As 
such, the two entities only overlapped partially (41.3 ± 8.5%). Thus, our results are consistent 
with the notion that TAX1BP1 co-localizes substantially with Tax and partially with PML.  
Evidence for coactivator function of TAX1BP1. We found unexpectedly that TAX1BP1 
fused to Gal4 DNA binding domain (GalBP1) potently activated transcription in yeast. This 
prompted us to investigate the transcriptional activity of TAX1BP1 in mammalian cells by co-
transfecting GalBP1 and a CAT reporter responsive to trans-activators containing Gal4 DNA 
binding domain (Fig. 4). Indeed, when the expression levels of GalBP1 and GalTax were 
comparable in HeLa cells as verified by confocal microscopy (data not shown), GalBP1 
activated transcription in a dose-dependent manner (Fig. 4B, columns 4-6) with a potency that 
resembles GalTax, a previously characterized transactivator (Fig. 4A, compare lane 3 to lane 2; 
Fig. 4B, compare column 4 to column 3). As expected, activation by GalVP16 was even more 
potent (Fig. 4B, column 2 compared to columns 3 and 4). Based on the activity profiles of four 
TAX1BP1 mutants (Fig. 4A), the activation domain in TAX1BP1 was mapped to residues 1-326. 
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Next we sought to determine the transcriptional activity of TAX1BP1 on Tax-responsive 
enhancers including the HTLV-1 LTR, κB motif, serum response element (SRE) and cellular 
cAMP response element (CRE). Because CoCoA is significantly homologous to TAX1BP1 and 
has been characterized to be a coactivator for NR-dependent transcription (24), which is 
regulated by Tax (7), we also tested the activity of TAX1BP1 on glucocorticoid response 
element (GRE). Since the activity of Tax and other coactivators such as CoCoA, GR and GRIP 
on GRE is known to be activated in the presence of steroids (7, 24), dexamethasone was used in 
some of our experiments. Interestingly, while the expression levels of TAX1BP1 in different 
groups of cells were similar as verified by Western blotting (Fig. 4C, inset), TAX1BP1 
stimulated GRE-dependent luciferase expression, but had no effect on HTLV-1 LTR, κB 
element, SRE or CRE (Fig. 4C, group 5 compared to groups 1-4). Furthermore, stimulation of 
GRE by TAX1BP1 occurred in a dose-dependent manner in cells (see the inset in Fig. 4D for 
verification of the expression levels of TAX1BP1) independent of treatment with dexamethasone 
(Fig. 4D, groups 1-4). Since CoCoA interacts with GRIP1 and functions as a secondary 
coactivator in the presence of GR and GRIP1 (24), we asked whether TAX1BP1 might have 
similar activity. Indeed, TAX1BP1 was able to further activate GRE-driven transcription in the 
presence of coactivators GR and GRIP1 (Fig. 4D, group 6 compared to group 5). Thus, 
TAX1BP1 is not only structurally related to but also functionally analogous with CoCoA; and 
both act as transcriptional coactivator for NRs.   
Tax inhibits the transcriptional activity of TAX1BP1. Earlier in this study, we 
demonstrated the interaction and co-localization of Tax and TAX1BP1 (Fig. 1 and Fig. 3). We 
also showed the coactivator activity of TAX1BP1 (Fig. 4). To shed light on the functional 
implications of the interaction between Tax and TAX1BP1, we considered two possibilities. 
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First, as a transcriptional coactivator, TAX1BP1 might modulate Tax-dependent transcriptional 
activity. In particular, Tax could recruit TAX1BP1 to Tax-responsive promoters to effect 
transcriptional activation. Second, Tax might also impact the cellular function of TAX1BP1.  
To investigate these two possibilities, we made use of GalTax and GalBP1; both potently 
activate transcription from a minimal promoter containing multiple Gal4-binding elements. We 
queried for the influence of TAX1BP1 and Tax by reciprocally increasing the dose of  the  
indicated expression plasmids. In the case of GalTax, transcriptional activity was totally 
unaffected when we increased the dose of TAX1BP1 plasmid progressively (Fig. 5A, groups 1-
4; see the inset for verification of the expression levels of TAX1BP1). In sharp contrast, a 
progressive increase in the dose of Tax plasmid led to significantly reduced GalBP1-dependent 
activation of CAT expression (Fig. 5A, group 5-8, □; see the inset for verification of the 
expression levels of Tax). As a control, expression of Tax did not affect the activity of GalVP16 
(Fig. 5A, group 5-8, ■). Hence, Tax can specifically repress the transcriptional activity of 
TAX1BP1.    
Next we examined the influence of TAX1BP1 on the activity of Tax on the HTLV-1 LTR, 
κB element and GRE. As expected, Tax potently activated transcription from HTLV-1 LTR and 
κB element (Fig. 5B, groups 1 and 2). Also in agreement with previous reports (7, 42), Tax 
repressed GRE-dependent transcription (Fig. 5B, group 3). Notably, the overexpression of 
TAX1BP1 did not influence Tax activation of HTLV-1 LTR or NFκB, but relieved the 
repression of GRE-mediated transcription by Tax (Fig. 5B, group 3 compared to groups 1 and 2). 
On the other hand, compared to TAX1BP1 alone (Fig. 4C, group 5), the expression of Tax 
eliminated the activation of GRE by TAX1BP1 (Fig. 5B, group 3).  
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Because the above experiments were conducted in transfected HeLa cells in which Tax and 
TAX1BP1 were transiently overexpressed, we sought to verify our findings in suspension T 
lymphocytes physiologically infected with HTLV-1. As a first step, we asked whether TAX1BP1 
and Tax ambiently expressed in HTLV-1-transformed MT4 cells (Fig. 1B) could be found in the 
GR-containing protein complex, which is known to mediate GRE-dependent transcription in 
response to hormone stimulation (21). We performed co-immunoprecipitation with rabbit anti-
GR antibodies and extracts of MT4 cells. The presence of GR in the immunoprecipitates was 
confirmed by Western blotting with a mouse anti-GR antibody (Fig. 5C). However, neither 
TAX1BP1 nor Tax was found in the GR-containing complexes obtained from untreated or 
dexamethasone-treated MT4 cells (Fig. 5C, lanes 1 and 2). In contrast, we were able to detect 
TAX1BP1 in the GR-containing complex from Tax-non-expressing Jurkat cells treated with 
dexamethasone, but not from untreated Jurkat cells (Fig. 5C, lane 4 compared to lane 3). Thus, 
TAX1BP1 is recruited to the GR-containing complex in Jurkat cells in a manner that depends on 
dexamethasone stimulation. This mechanism was abrogated in Tax-expressing MT4 cells leading 
to the absence of TAX1BP1 in the complex that mediates GRE-dependent transcription.  
To confirm our findings from co-immunoprecipitation, we assessed the biological effects of 
Tax and TAX1BP1 in JPX9 T-lymphocytes, in which the expression of Tax was driven by an 
inducible metallothionein promoter (26). The expression of TAX1BP1 and Tax in mock- and 
CdSO4-induced JPX9 cells was first confirmed by Western blot analysis (Fig. 5D, insets). 
Significant less GRE transcriptional activity was observed in JPX9 cells induced to express Tax 
than in mock-induced JPX9 cells (Fig. 5D, column 2 compared to column 1). In addition, 
enforced overexpression of TAX1BP1 in induced JPX9 cells led to the restoration of GRE 
activity to a level comparable to that of mock-induced JPX9 cells (Fig. 5D, column 3 compared 
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to columns 1 and 2). These results suggested that TAX1BP1 expressed in induced JPX9 cells 
was inactivated for transcriptional coactivation, likely through interaction with Tax.           
Finally, to establish the role of Tax1bp1 in Tax modulation of NR-dependent transcription, 
we tested the transcriptional activity of Tax in mouse embryonic fibroblasts (MEF) derived from 
Tax1bp1-disrupted mice (Fig. 6). We first perform Western blotting (Fig. 6A) to assess the 
expression of Tax1bp1 and α-tubulin in MEF cells derived from wild type (Tax1bp1+/+), 
heterozygous (Tax1bp1+/-) and homozygous (Tax1bp1-/-) Tax1bp-knockout mice, as well as in 
Tax1bp1-/- cells transfected with an expression plasmid for recombinant mouse Tax1bp1 
(rTax1bp1). The complete loss of Tax1bp1 expression in Tax1bp1-/- mice was verified (Fig. 6A, 
lane 3). We then compared the influence of Tax on the activation of HTLV-1 LTR (Fig. 6B) and 
GRE (Fig. 6C). We noted that the status of Tax1bp1 did not affect the stimulation of LTR by Tax 
(Fig. 6B). In contrast, the ability of Tax to repress GRE-dependent transcription was lost in 
Tax1bp1-/- cells, but not in the other three groups of cells in which Tax1bp1 is abundantly 
expressed (Fig. 6C, group 3 compared to groups 1, 2 and 4). Thus, Tax1bp1 is specifically 
required for Tax modulation of NR signaling. 
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Discussion 
In this study, we have identified and characterized TAX1BP1, a novel cellular protein that 
binds to HTLV-1 oncoprotein Tax. TAX1BP1 is a ubiquitously expressed coiled-coil protein, 
and it uses separate domains to interact with Tax and to form homodimers (Fig. 1). 
Intracellularly, TAX1BP1 concentrates in Tax-containing intranuclear speckles that partially 
overlap with PML (Fig. 2 and Fig. 3). Functionally, TAX1BP1 is a transcriptional coactivator for 
NRs (Fig. 4). While TAX1BP1 does not influence Tax activation of HTLV-1 LTR and NFκB, 
the expression of Tax inhibits TAX1BP1-mediated transcription in a dose-dependent manner 
(Fig. 5). In addition, while overexpression of TAX1BP1 in HeLa and HTLV-1-transformed cells 
causes a relief of Tax-induced repression of NR signaling (Fig. 5), disruption of Tax1bp1 in 
mouse cells abolished the repressive activity of Tax on NR (Fig. 6). Taken together, our findings 
suggest that Tax might inhibit NR-dependent transcription by targeting TAX1BP1.     
Tax targets a group of coiled-coil proteins. We have previously shown that Tax recognizes 
a particular coiled-coil structure shared by eight Tax-binding proteins including GPS2, MAD1, 
IKK-γ, TAX1BP1 and TAX1BP2 (23, 26, 27, 36, 43). The characterization of TAX1BP1 
provides new information on the properties of these coiled-coil proteins. Similar to MAD1, 
TAX1BP1 uses a coiled-coil domain to mediate its interaction with Tax (Fig. 1). In addition, 
TAX1BP1 is also capable of homodimerization. However, the dimerization domain of 
TAX1BP1 within the coiled-coil region is separable from the Tax-binding domain (Fig. 1). In 
other words, different coiled-coil subdomains of TAX1BP1 are responsible for Tax-binding and 
dimerization. This corroborates the notion that the coiled-coil domains in these proteins are for 
protein-protein interactions. 
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Newly identified Tax-binding proteins such as tropomyosin 5 and TORC1/2/3 also have a 
coiled-coil domain (17, 18, 38). In the case of TORC1/2/3, the Tax-binding domain is also 
within the coiled-coil region (17). Understandably, more Tax-binding coiled-coil proteins will be 
identified with the advent of new methods for proteomic analysis of Tax partners. We have 
previously identified IKK-γ as a new binding partner of Tax (27) based on sequence similarity to 
Tax-binding protein TAX1BP2 (36, 43). Since CoCoA is significantly homologous to TAX1BP1 
and acts as a coactivator for NR-mediated transcription (24), it will be of particularly great 
interest to elucidate whether CoCoA might also interact directly with Tax. 
Physiological function of TAX1BP1. One salient finding that emerges from our study is that 
TAX1BP1 can function as a transcriptional coactivator for NRs (Fig. 4). NRs are transcription 
factors that regulate various processes including cell growth and proliferation (21). NR 
coactivators are a large family of cellular factors recruited by NRs to complement their function 
in the activation of target genes (22). These coactivators could be broadly divided into three 
groups that are chromatin-remodeling factors, acetyltransferases and adaptors to basal 
transcription machinery. Well-known examples of coactivators include SWI/SNF, p160, 
CBP/p300 and TRAP/DRIP (21). CoCoA homologous to TAX1BP1 has been shown to interact 
specifically with the N-terminal region of p160 coactivators such as GRIP1 (24), which also 
localizes to PML oncogenic domains (44). We noted that GRE-dependent transcription was not 
significantly diminished in Tax1bp1-knockout cells (Fig. 6C). In that regard, other coactivators 
such as CoCoA might fulfill a redundant function in the absence of TAX1BP1. Nevertheless, 
additional experiments are required to determine whether TAX1BP1 directly interacts with 
CoCoA and GRIP1. It will also be of importance to investigate the mechanisms by which 
TAX1BP1 and CoCoA activate transcription.  
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Consistent with the coactivator function of TAX1BP1 for nuclear receptors (Fig. 4), we 
demonstrated that TAX1BP1 was recruited to the GR-containing protein complex in a hormone-
dependent manner (Fig. 5). The prevention of this recruitment in HTLV-1-transformed MT4 
cells provides one explanation for Tax-induced inhibition of TAX1BP1 function. Existing 
evidence suggests that Tax directly interacts with TAX1BP1 (Fig. 1) leading to its dissociation 
from the GR-containing complex critically involved in transcriptional activation (Fig. 5). Further 
elucidation of the direct protein partner(s) of TAX1BP1 in that complex will derive important 
mechanistic insight into the roles of TAX1BP1 in transcription.      
Our work does not preclude TAX1BP1 from other functions beyond transcriptional 
regulation. Previous studies have revealed several other binding partners of TAX1BP1 including 
A20, TRAF6 and Chfr (23, 34, 45). TAX1BP1 may also have cell cycle regulatory activity (our 
unpublished data). Although A20, TRAF6 and Chfr serve different functions in regulating 
NFκB, apoptosis, interleukin-1 signaling and mitotic progression, more recent studies suggest 
that all three have ubiquitin ligase and/or deubiquitinase activities (46-48). In addition, the 
ubiquitination of Tax has also been demonstrated (49). In light of this, we speculate that 
TAX1BP1 might be involved in some aspect of protein ubiquitination. Elsewhere TAX1BP1 is 
shown to be a repressor of TRAF6-mediated NFκB activation; and Tax1bp1-/- mice exhibit a 
hyper-inflammatory phenotype when exposed to interleukin-1, lipopolysaccharide or tumor necrosis 
factor α (Iha et al., in preparation). Thus TAX1BP1 may provide different adaptor roles and 
contributes different function depending on the protein-protein complexes into which it 
intercalates. Full clarification of TAX1BP1’s functions awaits further investigation.    
Tax- and TAX1BP1-containing intranuclear speckles. The subcellular localization of Tax 
has been well documented (39). Compared to the existing model, two additional points revealed 
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in our study are noteworthy. First, TAX1BP1 is a component of Tax-containing intranuclear 
speckles (Fig. 2 and Fig. 3). Second, these Tax- and TAX1BP1-containing speckles partially 
overlap with the PML oncogenic domains, also known as nuclear domains 10 (ND10) in the 
literature (Fig. 3).       
In support of the partial overlapping of the PML domains with speckles containing Tax and 
TAX1BP1, several proteins that are known to interact with Tax or TAX1BP1 have also been 
found in the PML domains. These include the CBP coactivator, p53, Chfr and HDACs (50). 
PML domains have been suggested to play a role in transcriptional control, tumor suppression, 
DNA repair, protein degradation and apoptosis (50). All these functions are highly relevant to 
Tax. Plausibly, the overlapping of Tax/TAX1BP1 with PML domains may provide an 
opportunity for their interaction with other components in that compartment. 
A model for Tax repression of NR signaling. We have presented several lines of evidence 
that support a new model for Tax repression of NR signaling. First, TAX1BP1 is a component of 
the NR-containing protein complex (Fig. 5) and it serves a transcriptional coactivator function 
for NRs (Fig. 4). Second, Tax interacts specifically with TAX1BP1 (Fig. 1). Third, the 
expression of Tax leads to dissociation of TAX1BP1 with NRs and diminution of NR-dependent 
transcription (Fig. 5). Finally, while the expression of TAX1BP1 relieves the inhibition of Tax 
repression of NR activity (Fig. 5), genetic knockout of Tax1bp1 in mice abrogates the repressive 
activity of Tax on NR (Fig. 6).  
 The above four lines of evidence are consistent with a model in which Tax interacts with and 
inhibits TAX1BP1 to affect NR activity. This new model explains the previous findings that Tax 
represses the transcriptional activity of NRs (7, 42).  
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Figure Legends 
Figure 1. Interaction between TAX1BP1 and Tax. A, schematic diagram of TAX1BP1 and 
CoCoA. The NDP52-homologous , coiled coil (CC) and zinc finger (ZF) domains are indicated. 
B, co-immunoprecipitation of Tax and TAX1BP1 from Tax-expressing HeLa cells and HTLV-1-
transformed MT4 cells. HeLa cells were mock transfected (lane 1) or transfected with TAX1BP1 
(lane 2) or Tax (lane 3). Crude cell extracts were analyzed by Western blotting with rabbit anti-
TAX1BP1 (α-151C) or mouse anti-Tax (α-Tax). Cell lysates were also immunoprecipitated (IP) 
with either mouse α-Tax or rabbit α-151C. The α-Tax precipitate was blotted with α-151C and 
rabbit α-Tax. The α-151C precipitate was blotted with mouse α-Tax and another rabbit 
antiserum against TAX1BP1 (α-151A). C, GST pull-down assay. GST (lanes 1 and 2) and GST-
TAX1BP1 (GST-BP1; lanes 3 and 4) were bound to Sepharose resins. Resins were incubated 
with His-Tax, and bound proteins were then eluted. Flow-through (FT, lanes 1 and 3) and eluates 
(lanes 2 and 4) were analyzed by Western blotting with mouse α-Tax. D, mapping of Tax-
binding and dimerization domains in TAX1BP1. Interactions between the indicated pairs of 
proteins were defined by yeast two-hybrid analysis and scored by fold-activation in β-
galactosidase (β-gal) activity. The interactions were further confirmed by in vitro affinity 
binding assay (data not shown). Expression of M1, M3 and M5 mutants fused to Gal4 activation 
domain (AD-M1/3/5) was verified by Western blotting with anti-AD (inset). 
 
Figure 2. Subcellular localization of TAX1BP1 protein in cultured cells. A, localization of 
endogenous TAX1BP1. HeLa cells were stained with purified α-151C (panel 1), α-151C pre-
incubated with 3.5 µg of immunizing peptide (151C + pep.; panel 2), or α-151A (panel 7). Cells 
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were co-stained with mouse anti-α-tubulin (panels 2, 5 and 8). The TAX1BP1 (red) and α-
tubulin (green) fluorescent signals were then overlaid by computer assistance (panels 3, 6 and 9). 
The same fields are shown in panels 1-3, 4-6, and 7-9. Bar, 20 µm. B, localization of 
exogenously expressed TAX1BP1. HeLa cells were transfected with pHABP1 and stained with 
α-151C (lane 1) and α-HA (lane 2). The TAX1BP1 (red; representing endogenous and 
transfected TAX1BP1) and HA (green; representing transfected TAX1BP1) fluorescent signals 
were overlaid in panel 3. Co-localizations are shown in yellow. The same fields are shown in 
panels 1-3. The arrow indicates transfected cell. Results represent three independent experiments 
and 84.3 ± 4.5% co-localization was detected for 150 transfected cells analyzed. Bar, 20 µm. 
 
Figure 3. Co-localization of TAXBP1 with Tax and PML. A, co-localization of TAX1BP1 with 
Tax. HeLa cells transiently transfected with Tax-expressing plasmid were co-stained with α-
151C (panel 1) and α-Tax (panel 2) antibodies. In panel 3, the TAX1BP1 (red) and Tax (green) 
fluorescent signals were overlaid by computer assistance. Co-localizations are in yellow. The 
same fields are shown in panels 1-3. Arrows indicate transfected cells. Results are representative 
of three independent experiments and 89.1 ± 5.2% co-localization of the two fluorescent signals 
was detected for 150 transfected cells analyzed. Bar, 20 µm. B, co-localization of Tax with PML. 
HeLa cells transiently transfected with Tax-expressing plasmid were co-stained with α-Tax 
(panel 1) and α-PML (panel 2) antibodies. In panel 3, the Tax (red) and PML (green) fluorescent 
signals were overlaid by computer assistance. Co-localizations are in yellow. The same fields are 
shown in panels 1-3. Results are representative of three independent experiments and 48.5 ± 
6.0% co-localization was detected for 150 transfected cells analyzed. Bar, 20 µm. C, co-
localization of TAX1BP1 with PML. HeLa cells were co-stained with α-151C (panel 1) and α-
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PML (panel 2) antibodies. In panel 3, the TAX1BP1 (red) and PML (green) fluorescent signals 
were overlaid by computer assistance. Co-localizations are in yellow. The same fields are shown 
in panels 1-3. Results are representative of three independent experiments and 41.3 ± 8.5% co-
localization was detected for 150 cells analyzed. Bar, 20 µm. 
 
Figure 4. TAX1BP1 is a transcriptional coactivator. A, mapping of the trans-activation domain 
in TAX1BP1. HeLa cells were transiently transfected with 1 µg of pG5CAT reporter and 5 µg of 
plasmids expressing Gal4 DNA binding domain (Gal; lane 1), GalTax (lane 2), GalBP1 (lane 3), 
GalBP1 mutant M8 (GalBP1M8; lane 4) and GalBP1 mutant M9 (GalBP1M9; lane 5). CAT 
assays were performed 48 hours after transfection. Summarized on the right are transactivation 
activities of different TAX1BP1 fusion proteins (BP1: GalBP1 wild-type; M8, M9, M1 and M2: 
GalBP1 mutants). The activity was scored by fold-activation  (+++ > 10; 5 < ++ < 10; 2 < + < 5; 
- < 2). AcCM: acetyl chloramphenicol. CM: chloramphenicol. B, TAX1BP1 activates 
transcription in a dose-dependent manner when targeted to a minimal promoter. HeLa cells were 
transfected with pG5CAT reporter and plasmids expressing the indicated proteins. Decreasing 
amounts (5, 2 and 1 µg) of GalBP1 plasmids were added to cells (columns 4-6), while 5 µg of 
plasmids expressing all other Gal or Gal fusion proteins were used in the transfection (columns 
1, 2, 3, 4, 7 and 8). The expression of Gal and Gal fusion proteins was verified by confocal 
microscopy. The transfection efficiency was normalized by pSV-β-Gal. The results are the 
average from three independent experiments and error bars indicate standard deviations. C, 
coactivator activity of TAX1BP1 on different enhancers. HeLa cells were transfected with 
luciferase reporter plasmids (100 ng) driven by the indicated enhancer elements. A TAX1BP1 
expression plasmid (100 ng) was either given (■; w/ BP1) or not given (□; w/o BP1) to cells in 
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each group. Cells in group 5 were also treated with 1 µM dexamethasone for 12 hours before 
harvest. Dual luciferase assay was performed. Firefly luciferase activity was measured by 
arbitrary units (au) and normalized to Renilla luciferase activity. The graph represents three 
independent experiments and similar results were also obtained in Jurkat cells (data not shown). 
The expression of TAX1BP1 in different groups of cells was verified by Western blotting (inset). 
D, coactivator activity of TAX1BP1 on GRE. Fixed amounts of pGRELuc reporter plasmid (50 
ng) and increasing amounts (0, 50 ng, 150 ng and 450 ng) of TAX1BP1 expression plasmid were 
given to HeLa cells (groups 1-4) treated (■; w/ Dex) or not treated (□; w/o Dex) with  1 µM 
dexamethasone (Dex). Cells in groups 5 and 6 received pGRELuc reporter (50 ng) and 
expression plasmids pCDNArGR and pSG5TIF2 (75 ng each) for GR and GRIP. In addition, 
cells in group 6 were cotransfected with TAX1BP1 expression plasmid (100 ng). Dual luciferase 
assay was performed as in C. Expression of TAX1BP1 in cells (groups 2-4) was verified by 
Western blotting (inset).  
 
Figure 5. Tax inhibits the coactivator activity of TAX1BP1. A, influence of TAX1BP1 on Tax 
activity (groups 1-4) and influence of Tax on TAX1BP1 activity (groups 5-8). For groups 1-4, 
HeLa cells were transfected with pG5CAT reporter (1 µg), GalTax plasmid (5 µg) and 
increasing amounts of TAX1BP1 plasmid (0 to 5 µg). For groups 5-8, HeLa cells were 
transfected with pG5CAT reporter (1 µg), GalBP1 (□) or GalVP16 (■) plasmid (5 µg) and 
increasing amounts of Tax plasmid (0 to 5 µg). Expression of BP1 and Tax in cells (groups 2-4 
and groups 6-8, respectively) was verified by Western blotting (insets). B, inhibition of GRE 
activity by Tax can be rescued by overexpression of TAX1BP1. HeLa cells were transfected 
with luciferase reporter plasmids driven by the indicated enhancer elements. Cells in each group 
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received neither Tax nor TAX1BP1 (□; basal), Tax alone (□; Tax), or both Tax and TAX1BP1 
(■; Tax + BP1). Cells in group 3 were also treated with 1 µM dexamethasone for  12 hours 
before the assay. Dual luciferase assay was performed and normalized luciferase activity (luc. 
activity) was measured by arbitrary units (au). Similar results were obtained in three independent 
experiments and also in Jurkat cells. C, dissociation of TAX1BP1 from GR-containing complex 
in HTLV-1-transformed leukemic cells. MT4 and Jurkat (Jkt) T lymphocytes were mock-treated 
or treated with 1 µM dexamethasone for 12 hours. Cell lysates were immunoprecipitated (IP) 
with rabbit anti-GR. The precipitates were then blotted with rabbit anti-151C, mouse anti-Tax 
and mouse anti-GR. D, overexpression of TAX1BP1 can rescue the inhibition of GRE activity in 
Tax-expressing cells. JPX9 cells were transfected with pGRELuc reporter alone (groups 1 and 2) 
or with pGRELuc plus TAX1BP1 expression plasmid (group 3). Cells were treated with 1 µM 
dexamethasone for 12 hours. Cells were  mock-induced (group 1) or induced with 25 µM CdSO4 
for 3 hours (groups 2 and 3). Dual luciferase assay was performed as in C with the same amount 
of cell lysate from each group. Results represent three independent transfections. Expression of 
TAX1BP1 and Tax in cells was verified by Western blotting (inset). 
 
Figure 6. Genetic knockout of Tax1bp1 abolishes the repression of GRE by Tax. A, expression 
of Tax1bp1 in different groups of MEF cells. Western blot analysis of Tax1bp1 (BP1) and α-
tubulin was performed on lysates of MEF cells with wild type Tax1bp1 (lane 1), MEF cells with 
heterozygous deletion of Tax1bp1 (lane 2), MEF cells with  homozygous deletion of Tax1bp1 
(lane 3), and Tax1bp1-/- cells transfected with an expression plasmid for recombinant mouse 
Tax1bp1 (rTax1bp1, lane 4).  B, Tax activation of HTLV-1 LTR in MEF cells. The four groups 
of cells as described in A were transfected with Tax plasmid and LTR-luciferase reporter. C, Tax 
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activity on GRE in MEF cells. The four groups of cells as described in A were transfected with 
Tax plasmid and pGRELuc reporter. Cells were treated with 1 µM dexamethasone for 12 hours. 
Dual luciferase assay was performed and results represent the average normalized luciferase 
activity in arbitrary units (au) obtained from three independent experiments.     






